We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Regulators Approve Anemia Drug Turned Down by FDA
EU Regulators Approve Anemia Drug Turned Down by FDA
Astellas Pharma and Fibrogen have received EU approval for Evrenzo (roxadustat) for treating adults with anemia associated with chronic kidney disease (CKD) — mere days after the FDA rejected the drug for the same indication in the U.S.